BEaTS Research Radio's Podcast

Maheen Khanotia from the Translational Molecular Medicine program interviews Dr. Barabara Vanderhyden, a distinguished researcher at the Ottawa Hospital and a professor at the University of Ottawa. She is a leading researcher in ovarian cancer, focusing on the BRCA1 and BRCA2 mutations. In this podcast, Maheen discusses with Dr. Vanderhyden her key findings in her 2023 paper "BRCA1 and BRCA2 deficient tumor models generate distinct ovarian tumor microenvironments and differential responses to therapy," where they delve into the world of cancer, Dr. Vanderhyden's lab findings, potential treatments, and research advice.Learn more:  https://www.ohri.ca/profile/vanderhydenlab/profile0:05 | BEaTS and host introduction.1:17 | Introduction to Dr. Barbara Vanderhyden.1:39 | How did you come to study ovarian cancer?2:48 | What led you to believe the BRCA1 and BRCA2 mutations are different?3:50 | What is the tumor microenvironment? 4:57 |  What do the research findings mean to the general public?6:05 | W